Evidence map›Paper›PMID 31524302›Full record

ReviewRisk analysis : an official publication of the Society for Risk Analysis2020

Extended Analysis and Evidence Integration of Chloroprene as a Human Carcinogen.

Sonja N Sax, P Robinan Gentry, Cynthia Van Landingham, Harvey J Clewell, Kenneth A Mundt

Open access · hybridAbstract readReview
In one paragraph

Review in Risk analysis : an official publication of the Society for Risk Analysis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Analysis of Regulatory Inhalation Unit Risk Estimates for Cobalt: Comparison to Epidemiological Data.Risk analysis : an official publication of the Society for Risk Analysis · 2026
    Article
  2. Ethylene Oxide: Cancer Evidence Integration and Dose-Response Implications.Dose-response : a publication of International Hormesis Society
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Sonja N SaxRamboll US Corporation, Amherst, MA, USA.
P Robinan GentryRamboll US Corporation, Monroe, LA, USA.
Cynthia Van LandinghamRamboll US Corporation, Monroe, LA, USA.
Harvey J ClewellRamboll US Corporation, Research Triangle Park, NC, USA.
Kenneth A MundtCardno Chemrisk, Boston, MA, USA.
United States Gypsum (United States) · USEntegris (United States) · USENVIRON (United States) · USTriangle · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β-Chloroprene is used in the production of polychloroprene, a synthetic rubber. In 2010, Environmental Protection Agency (EPA) published the Integrated Risk Information System "Toxicological Review of Chloroprene," concluding that chloroprene was "likely to be carcinogenic to humans." This was based on findings from a 1998 National Toxicology Program (NTP) study showing multiple tumors within and across animal species; results from occupational epidemiological studies; a proposed mutagenic mode of action; and structural similarities with 1,3-butadiene and vinyl chloride. Using mouse data from the NTP study and assuming a mutagenic mode of action, EPA calculated an inhalation unit risk (IUR) for chloroprene of 5 × 10

Indexed as

Carcinogenicity TestsCarcinogensAdministration, InhalationAnimalsChloropreneCricetinaeHumansKineticsMiceModels, AnimalRatsRisk AssessmentUnited StatesUnited States Environmental Protection AgencyCarcinogensChloropreneCancer inhalation unit riskchloropreneevidence integrationinterspecies extrapolationpharmacokinetic modeling

Identifiers

PMID31524302
PMCPMC7028114
OpenAlexW2974607041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.